Aratana Therapeutics secures USDA conditional license for canine osteosarcoma vaccineJanuary 10, 2018Aratana Therapeutics announced that its canine osteosarcoma vaccine, Live Listeria Vector (AT-014), has been granted a conditional license by the USDA Center for Veterinary Biologics for the treatment of dogs diagnosed with osteosarcoma, 1 year of age or older. The vaccine is a novel immunotherapy developed by using a listeria-based antigen delivery system licensed from Advaxis Inc. "Osteosarcoma is the most common primary bone tumor in dogs and, …
SPONSORED CONTENTA new way to offer multi-organ supportNEW Hill's Prescription Diet Multi-Organ offers therapeutic nutrition for pets that may have conflicting nutritional needs. + Learn More
Synthetic Genomics, Ceva partner to develop livestock vaccinesNovember 1, 2017 Synthetic Genomics Inc. announced that it has partnered with Ceva Santé Animale to utilize Synthetic Genomics' next-generation synthetic RNA replicon platform to develop vaccines for livestock. Synthetic Genomics' RNA replicons are programed to deliver genetic instructions to a body's own cells to unleash a powerful immune response against a specific disease, the company said. These RNA replicons carry the genetic code for a self-replication engine as well …
Canine rabies vaccination promises unexpected benefitsSeptember 28, 2017 New research funded by Morris Animal Foundation shows the rabies vaccine may have a positive impact on overall canine health and is associated with a decrease in death from all causes. Darryn Knobel, BVSc MSc MRCVS PhD, associate professor of epidemiology and population health at Ross University School of Veterinary Medicine recently published his research results in the journal Vaccine. What the findings show The study found that vaccination …
UA researchers get $4.8 million to develop valley fever vaccineSeptember 6, 2017The University of Arizona's (UA) efforts to prevent valley fever in dogs received a boost in the way of a $4.8 million, four-year grant from the National Institutes of Health, providing the funding necessary to get the disease's delta-CPS1 vaccine to market, according to John Galgiani, MD, director of the UA Valley Fever Center for Excellence and principal investigator of the NIH grant. The …
AAHA releases 2017 Canine Vaccination GuidelinesSeptember 5, 2017The American Animal Hospital Association (AAHA) has released its newly revised Canine Vaccination Guidelines. Experts and veterinary practitioners believe vaccination protocols should be individualized based on the patient's risk factors, life stage, and lifestyle, according to the Lakewood, Colo.-based organization. Published in the September/October edition of the Journal of the American Animal Hospital Association—and for the first time as an online educational resource for the veterinary medical profession—these revised …
The Immunity Challenge: Vaccines and petsJune 22, 2017Back in the day, dog and cat vaccines were cut and dry, and all pets were vaccinated annually, except perhaps for very old or sick animals. Today, the subject is much more fluid, as more information comes to light regarding duration of immunity, potential negative outcomes from vaccinating too often and adverse vaccine events.
Chinese vaccine lab to move into KC Animal Health CorridorJune 1, 2017KC Animal Health Corridor of Kansas City, Mo., will soon be getting some new neighbors in its new K-State Office Park Phase II building. That’s because Jinyu Bio-technology Co., Ltd. (also known as Jinyu Corp), has announced will open a vaccine research lab and office in the new building in 2018.
Zoetis: Lepto vaccine may be used with all maresDecember 30, 2016The equine leptospirosis vaccine Lepto EQ Innovator is now approved for use in broodmares during the entire pregnancy, manufacturer Zoetis Inc. reported.
Boehringer to sell vaccine lines to ElancoOctober 5, 2016Elanco Animal Health plans to acquire more than 40 vaccines from Boehringer Ingelheim Vetmedica Inc. in a transaction valued at $885 million, the companies announced today.
New feline core vaccine available from BIVIAugust 18, 2016Boehringer Ingelheim Vetmedica Inc. has released a reduced-volume core vaccine for cats. The nonadjuvanted Ultra Hybrid FVRCP is administered in a 0.5 mL subcutaneous dose to protect against feline herpesvirus, calicivirus infection and distemper in cats at least 8 weeks old.
